4
78 Letters in Drug Design & Discovery, 2016, Vol. 13, No. 6
Grün et al.
300
200
100
0
O
HO
O
HO
P
OH
P ONa
OH
H
2
N
2
H N
OH
P
OH
P
HO
O
OH
-
-
-
100
200
300
HO
O
O
HO
O
ONa
OH
HO
P
ONa
OH
P
H
2
N
2
H N
HO P OH
O
HO P ONa
O
0
1
2
3
4
5
6
7
8
9
10
Volume [mI]
Fig. (1). Titration curve for pure pamidronic acid (2) obtained by the reaction presented in Table 2/Entry 8.
[
8]
9]
Russell, R. G. G.; Rogers, M. J. Bisphosphonates: from the
laboratory to the clinic and back again. Bone, 1999, 25, 97-106.
Roelofs, A. J.; Thompson, K.; Gordon, S.; Rogers, M. J. Molecular
mechanisms of action of bisphosphonates: Current status. Clin.
Cancer. Res., 2006, 12, 6222-6230.
PCP), 36.5 (t, J = 7.5, NCH
5.3 (t, J = 133.0, PCP), 39.0 (t, J = 7.7, NCH
NCH ).
2
CH
2
), 30.8 (s, NCH
2
), ꢀ [16]:
2
), 33.3 (s,
7
2
CH
[
2
[
10]
Krueger, F.; Bauer, L.; Michel, W. 1-Hydroxy-3-aminopropane-
1,1-diphosphonic acid – prepn. from beta-alanine and phosphorus
trihalide, used as complexant. DE2130794; Chem. Abstr., 1973, 78,
CONFLICT OF INTEREST
The authors confirm that this article content has no
conflict of interest.
5
28.
[11]
Zhibo, Q.; Xiaolan, C.; Chen, Q.; Lingbo, Q.; Jinwei, Y.; Donghui,
W.; Huina, L.; Xiaoying, H.; Yuqin, J.; Yufen, Z. Fragmentation
pathways of eight nitrogen-containing bisphosphonates (BPs)
n
investigated by ESI-MS in negative ion mode. Int. J. Mass.
ACKNOWLEDGEMENTS
Spectrom., 2010, 295, 85-93.
The research was supported by Gedeon Richter Plc and
by Hungarian Scientific and Research Fund (OTKA K83118
and K115421).
[12]
Gore, V. G.; Shukla, V. K.; Ghadge, M. M.; Avadhut, R. M. Novel
process for the preparation of bisphosphonic acids.
WO2008004000; Chem. Abstr., 2008, 148, 100730.
[13]
Kieczykowski, G. R.; Jobson, R. B.; Melillo, D. G.; Reinhold, D.
F.; Grenda, V. J.; Shinkai, I. Preparation of (4-amino-1-
hydroxybutylidene)bisphosphonic acid sodium salt, MK-217
REFERENCES
(
alendronate sodium). An improved procedure for the preparation
of 1-hydroxy-1,1-bisphosphonic acids. J. Org. Chem., 1995, 60,
310–8312.
[
[
[
1]
2]
3]
Russell, R. G. G. Bisphosphonates: The first 40 years. Bone, 2011,
8
4
9, 2-19.
[
[
[
14]
15]
16]
Xie Y.; Ding H.; Qian L.; Yan X.; Yang C.; Xie Y. Synthesis and
biological evaluation of novel bisphosphonates with dual activities
on bone in vitro. Bioorg. Med. Chem. Lett., 2005, 15, 3267–3270.
Mustafa, D. A.; Kashemirov, B. A.; McKenna, C. E. Microwave-
assisted synthesis of nitrogen-containing 1-hydroxymethylenebi-
sphosphonate drugs. Tetrahedron Lett., 2011, 52, 2285-2287.
Kovács, R.; Grün, A.; Németh, O.; Garadnay, S.; Greiner, I.;
Keglevich, G. The synthesis of pamidronic derivatives in different
solvents: An optimization and a mechanistic study. Heteroatom
Chem., 2014, 25, 186-193.
Russell, R. G. G. Bisphosphonates: Mode of action and
pharmacology. Pediatrics, 2007, 119, S150-S162.
Breuer, E. The development of bisphosphonates as drugs, In
Analogue-Based Drug Discovery; Fischer, J.; Ganelli, C. R. (Eds.);
Wiley: Weinheim, Germany, 2006; Ch. 15.
Widler, L.; Jaeggi, K. A.; Glatt, M.; Müller, K.; Bahmann, R.;
Bisping, M.; Born, A.-R.; Cortesi, R.; Guiglia, G.; Jeker, H.; Klein,
R.; Ramseier, U.; Schmid, J.; Schreiber, G.; Seltenmeyer, Y.;
Green, J. R. Highly potent geminal bisphosphonates. From
pamidronate disodium (Aredia) to zoledronic acid (Zometa). J.
Med. Chem., 2002, 45, 3721-3738.
Hudson, H. R.; Wardle, N. J.; Blight, S. W. A.; Greiner, I.; Grün,
A.; Keglevich, G. N-Heterocyclic dronic acids; applications and
synthesis. Mini Rev. Med. Chem., 2012, 12, 313-325.
Rogers, M. J.; Frith, J. C.; Luckman, S. P.; Coxon, E. P.; Benford,
H. L.; Mönkkönen, J.; Auriola, S.; Chilton, K. M.; Russell, R. G.
G. Molecular mechanisms of action of bisphosphonates. Bone,
[4]
[
17]
18]
De Ferra, L.; Turchetta. S.; Massardo, P.; Casellato, P. Preparation
of biphosphonic acids and salts thereof. WO2003093282, 2003.
Martínez-Palou, R. J. Ionic liquid and microwave-assisted organic
synthesis: A “green” and synergic couple. Mex. Chem. Soc., 2007,
[
5]
6]
[
5
1, 252-264.
[
[
19]
20]
Zhang, Q.; Zhang, S.; Deng, Y. Recent advances in ionic liquid
catalysis. Green Chem., 2011, 13, 2619-2637.
[
Olivier-Bourbigou, H.; Magna, L.; Morvan, D. Ionic liquids and
catalysis: Recent progress from knowledge to applications. Appl.
Catal. A., 2010, 373, 1-56.
1
999, 24(Suppl.), 73S-79S.
[
7]
Russell, R. G. G.; Croucher, P. I.; Rogers, M. J. Bisphosphonates:
pharmacology, mechanisms of action and clinical uses.
Osteoporosis Int., 1999, 9, S66-S80.